These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9412570)

  • 21. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization.
    Sato H; Silveira L; Fingerlin T; Dockstader K; Gillespie M; Lagan AL; Lympany P; Sawyer RT; du Bois RM; Welsh KI; Maier LA
    J Allergy Clin Immunol; 2007 Mar; 119(3):687-96. PubMed ID: 17208287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum angiotensin converting enzyme activity in chronic beryllium disease.
    Newman LS; Orton R; Kreiss K
    Am Rev Respir Dis; 1992 Jul; 146(1):39-42. PubMed ID: 1320822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease.
    Li L; Hamzeh N; Gillespie M; Elliott J; Wang J; Gottschall EB; Mroz PM; Maier LA
    PLoS One; 2015; 10(2):e0117276. PubMed ID: 25689051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
    Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
    Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble IL-6 and TNF receptors release by polymorphonuclear and mononuclear cells in cancer patients.
    Jablonska E
    Neoplasma; 1999; 46(1):35-9. PubMed ID: 10355532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compartmentalized immune response reflects clinical severity of beryllium disease.
    Newman LS; Bobka C; Schumacher B; Daniloff E; Zhen B; Mroz MM; King TE
    Am J Respir Crit Care Med; 1994 Jul; 150(1):135-42. PubMed ID: 8025739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beryllium-stimulated apoptosis in macrophage cell lines.
    Sawyer RT; Fadok VA; Kittle LA; Maier LA; Newman LS
    Toxicology; 2000 Aug; 149(2-3):129-42. PubMed ID: 10967410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells.
    Huang H; Meyer KC; Kubai L; Auerbach R
    Lab Invest; 1992 Jul; 67(1):138-46. PubMed ID: 1625444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E; Pietruska Z
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
    Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
    Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease.
    Tinkle SS; Schwitters PW; Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
    Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
    Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
    Nozaki N; Yamaguchi S; Shirakabe M; Nakamura H; Tomoike H
    Jpn Circ J; 1997 Aug; 61(8):657-64. PubMed ID: 9276770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns.
    Paquet P; Piérard GE
    Int J Mol Med; 1998 Feb; 1(2):459-62. PubMed ID: 9852250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum levels of TNF-alpha, sTNF-RI and sTNF-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation.
    Haseeb MA; Shirazian DJ; Preis J
    Cytokine; 2001 Sep; 15(5):266-9. PubMed ID: 11594791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A
    Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
    Kacprzyk F
    Pol Merkur Lekarski; 2003 Oct; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevation of plasma-soluble tumour necrosis factor receptors (TNF-R) in sarcoidosis.
    Nakayama T; Hashimoto S; Amemiya E; Horie T
    Clin Exp Immunol; 1996 May; 104(2):318-24. PubMed ID: 8625527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.